Fate Therapeutics (FATE) Asset Utilization Ratio (2013 - 2026)

Fate Therapeutics has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.02 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 34.16% year-over-year to 0.02; the trailing twelve-month figure through Mar 2026 stood at 0.02 (down 34.16% YoY), and the FY2025 full-year result was 0.02, down 39.22% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.02, up from 0.02 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.2 in Q1 2023, with the low at 0.01 in Q1 2024.
• Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.03 in 2025.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 188.89% — and 2024, when it plunged 94.12%.
• Fate Therapeutics' Asset Utilization Ratio stood at 0.13 in 2022, then fell by 8.58% to 0.12 in 2023, then tumbled by 75.92% to 0.03 in 2024, then tumbled by 31.15% to 0.02 in 2025, then advanced by 4.28% to 0.02 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.